Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$61,168,870
-$6,239,259 QoQ
Shares Held
2,798,210
-3.0% QoQ
Ownership
3.13%
of shares outstanding
% of Portfolio
3.33%
of 13F equity value
Holder Rank
#8
of 238 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. SNDX ranks #4 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
913,880 | $121,783,648 | |
| 2 | VERA |
Vera Therapeutics, Inc.
|
2,212,770 | $94,949,960 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
1,785,941 | $66,454,864 | |
| 4 | SNDX |
Syndax Pharmaceuticals Inc
This page
|
2,798,210 | $61,168,870 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
664,684 | $52,702,794 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
798,973 | $45,389,656 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
629,952 | $36,619,109 | |
| 8 | GERN |
Geron Corp
|
18,717,422 | $23,958,300 |
All Filings in SNDX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,168,870 | 2,798,210 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $67,408,129 | 2,885,622 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $69,635,712 | 3,314,408 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $53,344,625 | 3,467,314 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,072,049 | 4,065,355 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $51,747,736 | 4,212,270 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,539,748 | 343,400 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $79,027,275 | 4,105,313 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $74,187,844 | 3,613,631 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $74,568,089 | 3,133,113 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $73,111,902 | 3,383,244 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $37,697,477 | 2,596,245 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $45,831,090 | 2,189,732 | Shares | Sole | 2023-11-08 | |
| 2023-03-31 | $46,655,283 | 2,209,057 | Shares | Sole | 2023-11-08 | |
| 2022-12-31 | $41,247,145 | 1,620,713 | Shares | Sole | 2023-11-08 | |
| 2022-09-30 | $29,110,759 | 1,211,434 | Shares | Sole | 2023-11-08 | |
| 2022-06-30 | $19,131,524 | 994,362 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||